AMGEN INC - 11 Jan 2022 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
10%+ Owner
Signature
By: /s/ Andrea A. Robinson, Vice President, Law, Governance and Securities & Assistant Secretary
Issuer symbol
VIGL
Transactions as of
11 Jan 2022
Net transactions value
$0
Form type
4
Filing time
11 Jan 2022, 20:33:07 UTC
Previous filing
06 Jan 2022
Next filing
14 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIGL Common Stock Conversion of derivative security +3,206,281 3,206,281 11 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Series A Preferred Stock Conversion of derivative security $0 -3,206,281 -100% $0.000000* 0 11 Jan 2022 Common Stock 3,206,281 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Series A Preferred Stock were converted into shares of the Issuer's common stock on a one-for-2.7732 basis upon the completion of the Issuer's initial public offering